Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
10 mg Prednisone
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 44 💬
215-day taper prednisone
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
3150-day taper prednisone
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
45 mg Prednisone
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 44 💬
55-Aminosalicylic acid(5-ASA) and/or Prednisone
(D00473)		[2] Aminosalicylic acid,
Prednisone		[2] Aminosalicylic acid ,
Prednisone (D00473) 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
6[Prednisone]
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[5] 19, 66, 90, 300, 303 💬
7Adalimumab, plus prednisone
(D00473)		[2] Adalimumab,
Prednisone		[2] Prednisone (D00473),
Adalimumab 💬 		[2] NR3C1,
TNF 💬 		[67] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 46 💬
8Administration of Methylprednisolone + Prednisone + Mycophenolate mofetil
(D00473)		[3] Methylprednisolone,
Mycophenolate mofetil,
Prednisone		[5] Methylprednisolone ,
Prednisone (D00473),
Mycophenolate mofetil ,
Methylprednisolone acetate ,
Mycophenolate mofetil hydrochloride 💬 		[3] IMPDH1,
IMPDH2,
NR3C1 💬 		[3] Drug metabolism - other enzymes, Neuroactive ligand-receptor interaction, Purine metabolism 💬[1] 49 💬
9Azathioprine/prednisone
(D00473)		[2] Azathioprine,
Prednisone		[3] Azathioprine ,
Prednisone (D00473),
Azathioprine sodium 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 85 💬
10Behavioral: Duchenne Muscular Dystrophy group with Prednisone/Predisolone
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 113 💬
11Capsule di prednisone
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 41 💬
12Chinese Herb Prescription Granule plus prednisone
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 66 💬
13Conventional Glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone)
(D00473)		[7] Acetate,
Cortisone,
Cortisone acetate,
Dexamethasone,
Hydrocortisone,
Prednisolone,
Prednisone		[8] Hydrocortisone ,
Dexamethasone ,
Prednisolone ,
Prednisone (D00473),
Cortisone acetate ,
Dexamethasone sodium phosphate ,
Cortisone ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 81 💬
14Corticosteroids (prednisone or prednisolone)
(D00473)		[2] Prednisolone,
Prednisone		[2] Prednisolone ,
Prednisone (D00473) 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 49, 223 💬
15Cyclophosphamide, Azathioprine,prednisone,methylprednisolone
(D00473)		[4] Azathioprine,
Cyclophosphamide,
Methylprednisolone,
Prednisone		[7] Azathioprine ,
Cyclophosphamide ,
Methylprednisolone ,
Prednisone (D00473),
Methylprednisolone acetate ,
Azathioprine sodium ,
Cyclophosphamide 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[3] 42, 43, 45 💬
16Cyclophosphamide-prednisone-azathioprine
(D00473)		[3] Azathioprine,
Cyclophosphamide,
Prednisone		[5] Azathioprine ,
Cyclophosphamide ,
Prednisone (D00473),
Azathioprine sodium ,
Cyclophosphamide 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 49 💬
17Glucocorticoid (prednisone or prednisolone)
(D00473)		[2] Prednisolone,
Prednisone		[2] Prednisolone ,
Prednisone (D00473) 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 84 💬
18Granulocyte-colony stimulating factor (G-CSF) and prednisone
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
19Hormone (prednisone)
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 66 💬
20Hydroxychloroquine + low-dose prednisone
(D00473)		[2] Hydroxychloroquine,
Prednisone		[3] Prednisone (D00473),
Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 84 💬
21Hydroxychloroquine + Prednisone
(D00473)		[2] Hydroxychloroquine,
Prednisone		[3] Prednisone (D00473),
Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 84 💬
22IR Prednisone
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
23Leflunomide 20 mg+prednisone 0.5mg/kg/d
(D00473)		[2] Leflunomide,
Prednisone		[2] Prednisone (D00473),
Leflunomide 💬 		[2] DHODH,
NR3C1 💬 		[2] Neuroactive ligand-receptor interaction, Pyrimidine metabolism 💬[2] 66, 223 💬
24Methylprednisolone (MP) or prednisone (pred)
(D00473)		[2] Methylprednisolone,
Prednisone		[3] Methylprednisolone ,
Prednisone (D00473),
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 66 💬
25Methylprednisolone pulses plus prednisone versus Cyclosporine A
(D00473)		[3] Cyclosporine,
Methylprednisolone,
Prednisone		[4] Cyclosporine ,
Methylprednisolone ,
Prednisone (D00473),
Methylprednisolone acetate 💬 		[6] NR3C1,
PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		[34] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[1] 223 💬
26Methylprednisone/Prednisone
(D00473)		[2] Methylprednisone,
Prednisone		[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 85 💬
27MR Prednisone
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
28Mycophenolate mofetil plus lower dose of Prednisone
(D00473)		[2] Mycophenolate mofetil,
Prednisone		[3] Prednisone (D00473),
Mycophenolate mofetil ,
Mycophenolate mofetil hydrochloride 💬 		[3] IMPDH1,
IMPDH2,
NR3C1 💬 		[3] Drug metabolism - other enzymes, Neuroactive ligand-receptor interaction, Purine metabolism 💬[1] 66 💬
29Optional Prednisone
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 127 💬
30Oral Prednisone
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
31Oral Prednisone - Hospital Dose Steroids
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
32Oral Prednisone 5mg
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 49 💬
33Other: Data collection for Prednisone metabolism
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 41 💬
34Other: prednisone
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
35Over encapsulated prednisone
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 41 💬
36Prednisolone/Prednisone
(D00473)		[2] Prednisolone,
Prednisone		[2] Prednisolone ,
Prednisone (D00473) 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 49 💬
37Prednisone
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[58] 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 127, 145, 162, 164, 205, 222, 223, 224, 228, 251, 269, 283, 284, 285, 288, 299, 300, 303, 307, 331 💬
38Prednisone (and methylprednisolone)
(D00473)		[2] Methylprednisolone,
Prednisone		[3] Methylprednisolone ,
Prednisone (D00473),
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 43 💬
39Prednisone (Cortancyl®)
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 63 💬
40Prednisone (Cortancyl®) alone followed by monitoring and standard of care
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 63 💬
41Prednisone + Inhibace/Cozaar
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 66, 223 💬
42Prednisone - Azathioprine
(D00473)		[2] Azathioprine,
Prednisone		[3] Azathioprine ,
Prednisone (D00473),
Azathioprine sodium 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 11 💬
43Prednisone 0,5 mg/kg orally on alternate days
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 222, 223 💬
44Prednisone 1 mg
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
45Prednisone 15 mg
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
46Prednisone 2 mg
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
47Prednisone 3 mg
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
48Prednisone 30 mg
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 222 💬
49Prednisone 4 mg
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
50Prednisone 45 mg
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 222 💬
51Prednisone 5 mg
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 46, 66 💬
52Prednisone 5 mg tablets
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 113 💬
53Prednisone 60 mg/meter square Body Surface Area
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 222 💬
54Prednisone 7.5 mg
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
55Prednisone acetate
(D00473)		[3] Acetate,
Prednisone,
Prednisone acetate		[2] Prednisone (D00473),
Prednisone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[9] 35, 40, 46, 49, 63, 66, 162, 222, 224 💬
56Prednisone Acetate Tablets
(D00473)		[3] Acetate,
Prednisone,
Prednisone acetate		[2] Prednisone (D00473),
Prednisone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 40, 224 💬
57Prednisone alone
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 11, 66 💬
58Prednisone and Belimumab
(D00473)		[2] Belimumab,
Prednisone		[2] Prednisone (D00473),
Belimumab 💬 		[2] NR3C1,
TNFSF13B 💬 		[5] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Rheumatoid arthritis 💬[1] 300 💬
59Prednisone and cyclophosphamide
(D00473)		[2] Cyclophosphamide,
Prednisone		[3] Cyclophosphamide ,
Prednisone (D00473),
Cyclophosphamide 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 66 💬
60Prednisone and Mycophenolate mofetil
(D00473)		[2] Mycophenolate mofetil,
Prednisone		[3] Prednisone (D00473),
Mycophenolate mofetil ,
Mycophenolate mofetil hydrochloride 💬 		[3] IMPDH1,
IMPDH2,
NR3C1 💬 		[3] Drug metabolism - other enzymes, Neuroactive ligand-receptor interaction, Purine metabolism 💬[1] 300 💬
61Prednisone and ustekinumab treatment
(D00473)		[2] Prednisone,
Ustekinumab		[2] Prednisone (D00473),
Ustekinumab 💬 		[4] IL12A,
IL12B,
IL23A,
NR3C1 💬 		[29] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Neuroactive ligand-receptor interaction, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 41 💬
62PREDNISONE ARROW 20mg
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 66 💬
63PREDNISONE ARROW 5 mg
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 66 💬
64Prednisone Capsule
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 41 💬
65Prednisone Capsules
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 41 💬
66Prednisone discontinuation
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 49 💬
67PREDNISONE DOC GENERICI
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 90 💬
68PREDNISONE DOC GENERICI - 5 MG COMPRESSE 10 COMPRESSE IN BLISTER PVC-PVDC/ALU
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 19 💬
69PREDNISONE DOC GENERICI - 5 MG COMPRESSE 30 COMPRESSE IN BLISTER PVC-PVDC/ALU
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 300 💬
70Prednisone in full dose
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 66 💬
71Prednisone monotherapy
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 300 💬
72Prednisone or Prednisolone
(D00473)		[2] Prednisolone,
Prednisone		[2] Prednisolone ,
Prednisone (D00473) 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 66, 84 💬
73Prednisone Oral Product
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
74Prednisone plus cyclophosphamide
(D00473)		[2] Cyclophosphamide,
Prednisone		[3] Cyclophosphamide ,
Prednisone (D00473),
Cyclophosphamide 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 66 💬
75Prednisone tablet
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 63 💬
76PredniSONE Tablets USP, 1 mg
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 41, 46 💬
77PredniSONE Tablets USP, 10 mg
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 41 💬
78PredniSONE Tablets USP, 1mg
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 41 💬
79PredniSONE Tablets USP, 2.5 mg
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 41 💬
80PredniSONE Tablets USP, 2.5mg
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 41 💬
81PredniSONE Tablets USP, 20mg
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 41 💬
82PredniSONE Tablets USP, 5 mg
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 41, 46 💬
83PredniSONE Tablets USP, 5mg
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 41 💬
84PredniSONE Tablets, USP
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[3] 41, 43, 44 💬
85PredniSONE Tablets, USP 10 mg
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 41 💬
86PredniSONE Tablets, USP 2.5 mg
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 41 💬
87PredniSONE Tablets, USP 5 mg
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 41 💬
88PredniSONE Tablets, USP, 1 mg
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 41 💬
89Prednisone therapy and pharmacokinetic
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 41 💬
90Prednisone treatment
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 41 💬
91Prednisone, ciclosporin and mycophenolate mofetil
(D00473)		[2] Mycophenolate mofetil,
Prednisone		[3] Prednisone (D00473),
Mycophenolate mofetil ,
Mycophenolate mofetil hydrochloride 💬 		[3] IMPDH1,
IMPDH2,
NR3C1 💬 		[3] Drug metabolism - other enzymes, Neuroactive ligand-receptor interaction, Purine metabolism 💬[1] 222 💬
92Prednisone, cyclophosphamide
(D00473)		[2] Cyclophosphamide,
Prednisone		[3] Cyclophosphamide ,
Prednisone (D00473),
Cyclophosphamide 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 40 💬
93Prednisone, FK506, MMF
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 222 💬
94Prednisone, low dose rituximab
(D00473)		[2] Prednisone,
Rituximab		[2] Prednisone (D00473),
Rituximab 💬 		[2] MS4A1,
NR3C1 💬 		[2] Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬[1] 61 💬
95Prednisone, methylprednisolone,cyclophosphamides
(D00473)		[2] Methylprednisolone,
Prednisone		[3] Methylprednisolone ,
Prednisone (D00473),
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[3] 42, 43, 45 💬
96Prednisone,methylprednisone and cyclophosphamide
(D00473)		[3] Cyclophosphamide,
Methylprednisone,
Prednisone		[3] Cyclophosphamide ,
Prednisone (D00473),
Cyclophosphamide 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 222 💬
97Prednisone/Methylprenisolone
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 96 💬
98Prednisone/Prednisolone
(D00473)		[2] Prednisolone,
Prednisone		[2] Prednisolone ,
Prednisone (D00473) 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 11, 35 💬
99Pyridostigmine, Prednisone, Tacrolimus
(D00473)		[3] Prednisone,
Pyridostigmine,
Tacrolimus		[4] Tacrolimus ,
Prednisone (D00473),
Pyridostigmine bromide ,
Tacrolimus 💬 		[7] ACHE,
NR3C1,
PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		[37] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Cholinergic synapse, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Glycerophospholipid metabolism, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[1] 11 💬
100RAYOS (delayed-release prednisone)
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
101Rituxan, Cyclophosphamide, Vincristine, Prednisone
(D00473)		[3] Cyclophosphamide,
Prednisone,
Vincristine		[5] Cyclophosphamide ,
Prednisone (D00473),
Vincristine sulfate ,
Cyclophosphamide ,
Vincristine 💬 		[10] NR3C1,
TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬 		[13] Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, IgSF CAM signaling, Motor proteins, Neuroactive ligand-receptor interaction, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬[1] 63 💬
102Sotatercept with prednisone boost
(D00473)		[2] Prednisone,
Sotatercept		[2] Prednisone (D00473),
Sotatercept 💬 		[2] ACVR2A,
NR3C1 💬 		[5] Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Neuroactive ligand-receptor interaction, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬[1] 284 💬
103Tacrolimus combined with prednisone
(D00473)		[2] Prednisone,
Tacrolimus		[3] Tacrolimus ,
Prednisone (D00473),
Tacrolimus 💬 		[6] NR3C1,
PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		[34] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[1] 222 💬
104Thalidomide, cyclophosphamide and prednisone
(D00473)		[3] Cyclophosphamide,
Prednisone,
Thalidomide		[4] Cyclophosphamide ,
Prednisone (D00473),
Thalidomide ,
Cyclophosphamide 💬 		[2] NR3C1,
TNF 💬 		[67] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 331 💬
105Thymectomy plus prednisone
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 11 💬
106Treatment systemic therapy (prednisone)
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 162 💬
107Treatment with systemic therapy (prednisone)
(D00473)		[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 162 💬
108Vinblastine, vincristine, prednisone, daunorubicin
(D00473)		[4] Daunorubicin,
Prednisone,
Vinblastine,
Vincristine		[8] Prednisone (D00473),
Vinblastine sulfate ,
Daunorubicin hydrochloride ,
Vincristine sulfate ,
Daunorubicin ,
Vinblastine ,
Vincristine ,
Daunorubicin citrate 💬 		[10] NR3C1,
TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬 		[13] Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, IgSF CAM signaling, Motor proteins, Neuroactive ligand-receptor interaction, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬[1] 65 💬